Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
No abstract available
